Rayonier Advanced Materials director Scott M. Sutton resigns from board

The governance change matters less as a standalone signal than as another data point that the strategic review is staying active and potentially contentious. In situations like this, director exits often imply either disagreement over process or a shrinking probability of a clean, board-endorsed outcome; that can increase the odds of a catalyst-driven rerating, but it also raises the risk of delay or a lower-quality transaction path. The market may be overfocusing on headline price action while underestimating how quickly optionality decays if the process stretches beyond the next 1-2 quarters.

The more interesting second-order effect is on deal architecture. If a prior private-equity indication was rejected, then any renewed bid likely needs to clear a higher bar, which can create a binary setup: either a takeout premium reappears, or the stock has to re-rate on fundamentals alone. That puts pressure on equity holders because the fundamental case for a sustained move is fragile when earnings power is still noisy and the rerating has already pulled forward a significant portion of the near-term catalyst.

From a trading perspective, the asymmetry is now less about owning the common outright and more about structuring around event timing. Near-dated upside remains possible if the review yields a concrete strategic action, but the downside becomes more pronounced if there is silence into the next filing cycle. The consensus seems to be treating the situation as a cleaner M&A story than it likely is; the more likely path is a choppy process with headline-driven volatility and limited follow-through unless a credible bidder emerges quickly.